Ranjith Kumavath Selected Research

Strophanthidin

1/2019

Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ranjith Kumavath Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 01/2016
4	Infections 02/2022 - 01/2020
2	Pseudomonas Infections 01/2022 - 06/2021
2	COVID-19 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	Heart Diseases (Heart Disease) 01/2021 - 08/2020
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2019
1	Congenital Abnormalities (Deformity) 01/2021
1	Persistent Infection 11/2020
1	Human Influenza (Influenza) 08/2020
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 08/2020
1	Communicable Diseases (Infectious Diseases) 04/2020
1	Drug Misuse 01/2020
1	Noncommunicable Diseases 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Lymphadenitis (Adenitis) 03/2013

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 02/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 04/2020
3	Cardiac GlycosidesIBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 01/2020
2	Aromatase (CYP19)IBA 01/2021 - 01/2016
2	EnzymesIBA 01/2021 - 01/2016
2	Adenosine Triphosphatases (ATPase)IBA 08/2020 - 11/2019
2	CateninsIBA 01/2020 - 01/2019
1	Vancomycin FDA LinkGeneric 02/2022
1	Virulence Factors (Pathogenicity Factors)IBA 06/2021
1	LignansIBA 06/2021
1	sesaminIBA 06/2021
1	sesamolinIBA 06/2021
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2021
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 08/2020
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2020
1	Antineoplastic Agents (Antineoplastics)IBA 08/2020
1	Viral RNAIBA 08/2020
1	Interleukin-8 (Interleukin 8)IBA 08/2020
1	cannogenin thevetoside (peruvoside)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Antimicrobial PeptidesIBA 01/2020
1	lanatoside CIBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	StrophanthidinIBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Aromatase InhibitorsIBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Biological ProductsIBA 03/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021